Nuffield Council on Bioethics2019-09-252019-09-252012-05-232002-071 904384 02 1http://hdl.handle.net/20.500.12424/185259"The remarkable development and application of new genetic technologies over the past 25 years has been accompanied by profound changes in the way in which research is commercialised in the life sciences. Many thousands of patents which assert rights over DNA sequences have been granted to researchers across the public and private sector. In general, we acknowledge the benefits that have accrued to society from the patent system, but we ask whether the application of the patent system to DNA sequences is achieving its goals, namely the stimulation of innovation for the public good, and the rewarding of people for useful new inventions." (p. xi)engWith permission of the license/copyright holderbioethicshealth ethicsDNAgeneticsBioethicsHealth ethicsThe ethics of patenting DNAConference proceedings